BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Policy

  Johnson & Johnson, Bayer AG Fall as FDA Staff Urges Xarelto Not Get Expanded Use

  September 6, 2011

   · 

  1 min read
• Policy

  FDA to Review Safety of Popular Bone Drugs like Merck & Co., Inc.'s Fosamax and Roche’s Boniva

  September 6, 2011

   · 

  1 min read
• BioCapital

  SANE Vax, Inc. Reports Human Papillomavirus (HPV) DNA Contamination in Gardasil(TM) to FDA: Requests Public Safety Investigation

  September 6, 2011

   · 

  2 min read
• Policy

  Discovery Laboratories Responds to FDA Concerns on Surfaxin

  September 6, 2011

   · 

  5 min read
• Drug Development

  4SC AG’s Resminostat Meets Primary Efficacy Endpoint in Phase II Trial in Hodgkin’s Lymphoma (HL)

  September 6, 2011

   · 

  3 min read
• FDA

  Hemosphere Receives CE Mark Approval for the HeRO(R) Graft

  September 6, 2011

   · 

  1 min read
• Business

  Case Western Reserve University Spinoff Looks to Commercialize “Cryo-Imaging” Technology

  September 6, 2011

   · 

  1 min read
• FDA

  Aeris Therapeutics, Inc.'s AeriSeal(R) System Receives Expanded EU Approval for Advanced Emphysema Therapy

  September 6, 2011

   · 

  2 min read
• Business

  Cancer-Detection Company Oncoscope Closes on $2 Million Fundraise

  September 6, 2011

   · 

  1 min read
• Drug Development

  Vertex Pharmaceuticals (MA) Arthritis Pill Shines in Phase II Study

  September 6, 2011

   · 

  11 min read